We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Measures biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion and supplementation in healthy males
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
The characteristics, diagnosis, management, surveillance and epidemiology of Pseudomonas aeruginosa.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Guidance to help local councils in developing policies for renewable and low carbon energy and identifies the planning considerations.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
Sets out COVID-19 testing for hospice patients and staff.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Find out about the long-term effects some people can have after having COVID-19.
This guidance provides information on COVID-19 in homelessness, domestic abuse refuge, respite room and asylum seeker accommodation settings.
The requirements for packaging DNLEU
Find out how to do a rapid lateral flow test for COVID-19. Rapid lateral flow tests show the result on a device that comes with the test.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.